TEL (ETV6)-AML1 (RUNX1) initiates self-renewing fetal pro-b cells in association with a transcriptional program shared with embryonic stem cells in mice

Stem Cells

Volumn 31, Issue 2, 2013, Pages 236-247

  Tsuzuki, Shinobu ^a   Seto, Masao ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Acute lymphocytic leukemia; B lymphocytes; Cancer stem cells; Self renewal

Indexed keywords

HYBRID PROTEIN; INTERLEUKIN 17; TEL AML1 PROTEIN; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL RENEWAL; CONTROLLED STUDY; EMBRYONIC STEM CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMOGENESIS; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ANIMALS; CELL CYCLE PROTEINS; CORE BINDING FACTOR ALPHA 2 SUBUNIT; EMBRYONIC STEM CELLS; FETUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HMGB3 PROTEIN; HOMEODOMAIN PROTEINS; LYMPHOCYTE COUNT; MICE; MICE, INBRED BALB C; ONCOGENE PROTEINS, FUSION; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR CELLS, B-LYMPHOID; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 84874303729     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1277     Document Type: Article

References (55)

1. Cobaleda C, Sanchez-Garcia I. B-cell acute lymphoblastic leukaemia: Towards understanding its cellular origin. Bioessays 2009;31:600-609.
2. Sarry JE, Murphy K, Perry R et al. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/ SCID/IL2Rcc-deficient mice. J Clin Invest 2011;121:384-395.
3. Goardon N, Marchi E, Atzberger A et al. Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. Cancer Cell 2011;19:138-152.
4. Cozzio A, Passegu E, Ayton PM et al. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev 2003;17:3029-3035. (Pubitemid 38040767)
5. Huntly BJP, Shigematsu H, Deguchi K et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 2004;6:587-596. (Pubitemid 40017702)
6. Krivtsov AV, Twomey D, Feng Z et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-F9. Nature 2006;442:818-822. (Pubitemid 44258912)
7. Greaves MF, Maia AT, Wiemels JL et al. Leukemia in twins: lessons in natural history. Blood 2003;102:2321-2333. (Pubitemid 37193565)
8. Ford AM, Bennett CA, Price CM et al. Fetal origins of the TELAML1 fusion gene in identical twins with leukemia. Proc Natl Acad Sci USA 1998;95:4584-4588. (Pubitemid 28207956)
9. Hong D, Gupta R, Ancliff P et al. Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia. Science 2008;319: 336-339.
10. Pine SR, Wiemels JL, Jayabose S et al. TEL-AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemia. Leuk Res 2003;27:155-164. (Pubitemid 36069081)
11. Weston VJ, McConville CM, Mann JR et al. Molecular analysis of single colonies reveals a diverse origin of initial clonal proliferation in B-precursor acute lymphoblastic leukemia that can precede the t(12;21) translocation. Cancer Res 2001;61:8547-8553. (Pubitemid 33131138)
12. Schindler JW, Van Buren D, Foudi A et al. TEL-AML1 corrupts hematopoietic stem cells to persist in the bone marrow and initiate leukemia. Cell Stem Cell 2009;5:43-53.
13. Tsuzuki S, Seto M, Greaves M et al. Modeling first-hit functions of the t (12; 21) TEL-AML1 translocation in mice. Proc Natl Acad Sci USA 2004;101:8443-8448. (Pubitemid 38736594)
14. Fischer M, Schwieger M, Horn S et al. Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model. Oncogene 2005;24:7579-7591. (Pubitemid 41638032)
15. Sabaawy HE, Azuma M, Embree LJ et al. TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2006;103:15166-15171. (Pubitemid 44583182)
16. Morrow M, Horton S, Kioussis D et al. TEL-AML1 promotes development of specific hematopoietic lineages consistent with preleukemic activity. Blood 2004;103:3890-3896. (Pubitemid 38596310)
17. Mori H, Colman SM, Xiao Z et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci USA 2002;99:8242-8247. (Pubitemid 34651037)
18. Bernardin F, Yang Y, Cleaves R et al. TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice. Cancer Res 2002;62:3904-3908. (Pubitemid 34791049)
19. van der Weyden L, Giotopoulos G, Rust AG et al. Modeling the evolution of ETV6-RUNX1-induced B-cell precursor acute lymphoblastic leukemia in mice. Blood 2011;118:1041-1051.
20. Tsuzuki S, Karnan S, Horibe K et al. Genetic abnormalities involved in t (12; 21) TEL-AML1 acute lymphoblastic leukemia: Analysis by means of array-based comparative genomic hybridization. Cancer Sci 2007;98:698-706. (Pubitemid 46563446)
21. Tsuzuki S, Seto M. Expansion of functionally defined mouse hematopoietic stem/progenitor cells by a short isoform of RUNX1/AML1. Blood 2012;119:727-735.
22. Magnusson M, Brun ACM, Miyake N et al. HOXA10 is a critical regulator for hematopoietic stem cells and erythroid/megakaryocyte development. Blood 2007;109:3687-3696. (Pubitemid 46641717)
23. DeKoter RP, Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU. 1. Science 2000;288: 1439-1441.
24. Kulessa H, Frampton J, Graf T. GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Genes Dev 1995;9:1250-1262.
25. Parikh C, Subrahmanyam R, Ren R. Oncogenic NRAS rapidly and efficiently induces CMML-and AML-like diseases in mice. Blood 2006;108:2349-2357. (Pubitemid 44497519)
26. Zuber J, Radtke I, Pardee TS et al. Mouse models of human AML accurately predict chemotherapy response. Genes Dev 2009;23: 877-889.
27. Pallisgaard N, Clausen N, Schroder H et al. Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative realtime RT-PCR exemplified by t (12; 21) TEL-AML1 fusion transcript. Gene Chromosome Canc 1999;26:355-365. (Pubitemid 29529581)
28. Vieira P, Cumano A. Differentiation of B lymphocytes from hematopoietic stem cells. Methods Mol Biol 2004;271:67-76.
29. Case M, Matheson E, Minto L et al. Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia. Cancer Res 2008;68:6803-6809.
30. Tsuzuki S, Taguchi O, Seto M. Promotion and maintenance of leukemia by ERG. Blood 2011;117:3858-3868.
31. Wong DJ, Liu H, Ridky TW et al. Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2008;2: 333-344. (Pubitemid 351455242)
32. Assou S, Le Carrour T, Tondeur S et al. A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells 2007;25:961-973. (Pubitemid 46572593)
33. Ben-Porath I, Thomson MW, Carey VJ et al. An embryonic stem celllike gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008;40:499-507. (Pubitemid 351601215)
34. Somervaille TCP, Matheny CJ, Spencer GJ et al. Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. Cell Stem Cell 2009;4:129-140.
35. Speck NA, Gilliland DG. Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer 2002;2:502-513. (Pubitemid 37328932)
36. Panzer-Grumayer ER, Cazzaniga G, van der Velden VHJ et al. Immunogenotype changes prevail in relapses of young children with TELAML1- positive acute lymphoblastic leukemia and derive mainly from clonal selection. Clinic Cancer Res 2005;11:7720-7727. (Pubitemid 41611614)
37. Eguchi-Ishimae M, Eguchi M, Ishii E et al. Breakage and fusion of the TEL (ETV6) gene in immature B lymphocytes induced by apoptogenic signals. Blood 2001;97:737-743. (Pubitemid 32113408)
38. Olsen M, Madsen HO, Hjalgrim H et al. Preleukemic TEL-AML1- positive clones at cell level of 10(-3) to 10(-4) do not persist into adulthood. J Pediatr Hematol Oncol 2006;28:734-740. (Pubitemid 44786437)
39. Aguiar RCT, Sohal J, Van Rhee F et al. TEL-AML1 fusion in acute lymphoblastic leukaemia of adults. Br J Hematol 1996;95:673-677. (Pubitemid 26423371)
40. Jabbar Al-Obaidi MS, Martineau M, Bennett CF et al. ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia. Leukemia 2002;16:669-674. (Pubitemid 34449749)
41. Wong DJ, Segal E, Chang HY. Stemness, cancer and cancer stem cells. Cell Cycle 2008;7:3622-3624.
42. Mullighan CG, Su X, Zhang J et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 2009;360:470-480.
43. Sala A. B-MYB, a transcription factor implicated in regulating cell cycle, apoptosis and cancer. Eur J Cancer 2005;41:2479-2484. (Pubitemid 41540624)
44. Brault L, Gasser C, Bracher F et al. PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers. Haematologica 2010;95:1004-1015.
45. Wotton D, Massague J. Smad transcriptional corepressors in TGF beta family signaling. Curr Topics Microbiol Immunol 2001;254:145-164.
46. Nemeth MJ, Curtis DJ, Kirby MR et al. Hmgb3: An HMG-box family member expressed in primitive hematopoietic cells that inhibits myeloid and B-cell differentiation. Blood 2003;102:1298-1306. (Pubitemid 36988036)
47. Nemeth MJ, Kirby MR, Bodine DM. Hmgb3 regulates the balance between hematopoietic stem cell self-renewal and differentiation. Proc Natl Acad Sci USA 2006;103:13783-13788. (Pubitemid 44413985)
48. Mikkers H, Nawijn M, Allen J et al. Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors. Mol Cell Biol 2004;24:6104-6115. (Pubitemid 38787993)
49. Powers SE, Taniguchi K, Yen W et al. Tgif1 and Tgif2 regulate Nodal signaling and are required for gastrulation. Development 2010; 137:249-259.
50. Ford AM, Fasching K, Panzer-Grumayer ER et al. Origins of ''late'' relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes. Blood 2001;98:558-564.
51. Konrad M, Metzler M, Panzer S et al. Late relapses evolve from slow-responding subclones in t (12; 21)-positive acute lymphoblastic leukemia: Evidence for the persistence of a preleukemic clone. Blood 2003;101:3635-3640. (Pubitemid 36857953)
52. Zuna J, Ford AM, Peham M et al. TEL deletion analysis supports a novel view of relapse in childhood acute lymphoblastic leukemia. Clin Cancer Res 2004;10:5355-5360. (Pubitemid 39100471)
53. Anderson K, Lutz C, van Delft FW et al. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 2010;469: 356-361.
54. Kuster L, Grausenburger R, Fuka G et al. ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling. Blood 2011;117: 2658-2667.
55. van Delft FW, Horsley S, Colman S et al. Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia. Blood 2011;117: 6247-6254.